000169146 001__ 169146
000169146 005__ 20260220162133.0
000169146 0247_ $$2doi$$a10.1016/j.acuro.2025.501919
000169146 0248_ $$2sideral$$a148231
000169146 037__ $$aART-2025-148231
000169146 041__ $$aspa
000169146 100__ $$aGómez Rivas, J.
000169146 245__ $$aEl futuro del cribado del cáncer de próstata en la Unión Europea: programa PRAISE-U
000169146 260__ $$c2025
000169146 5203_ $$antroduction: Prostate cancer (PCa) remains one of the leading public health challenges among European men. Despite technological advances, its early detection continues to be controversial due to the risk of overdiagnosis and the limited adoption of organized screening programs. Materials and methods: A review was conducted of scientific literature, institutional reports, and technical documentation from the PRAISE-U project. We describe the key components of its design, implementation and lessons learned at two pilot sites in Spain (Galicia and Manresa), with a focus on personalized strategies and operational efficiency. Results: Based on the European Union recommendation of 2022, the PRAISE-U project promotes a risk-based screening program that incorporates prostate-specific antigen (PSA), magnetic resonance imaging (MRI) and risk calculators (RC). Galicia and Manresa have developed screening circuits adapted to their health systems. Galicia has managed to invite 7,000 of the 12,000 target men in less than a year, integrating digital tools and direct contact strategies. Manresa, from primary care, has developed a coordinated approach focused on accessibility and traceability. Both models prioritize equity, adherence and minimization of overtreatment. Conclusions: The PRAISE-U project offers an innovative and adaptable framework for PCa screening in Europe. The Spanish experience demonstrates that it is possible to implement effective and risk-focused early detection programs, provided that there is sound planning, technological tools and a collaborative approach between levels of care.
000169146 536__ $$9info:eu-repo/grantAgreement/EU4HEALTH 101101217
000169146 540__ $$9info:eu-repo/semantics/closedAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000169146 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000169146 700__ $$aGómez Dávila, P.
000169146 700__ $$aTarrazo Antelo, A.M.
000169146 700__ $$aCorujo Quinteiro, M.
000169146 700__ $$aGómez Amorín, Á.
000169146 700__ $$aRodríguez Alonso, A.
000169146 700__ $$aVilaseca, J.M.
000169146 700__ $$aLópez, H.
000169146 700__ $$aSalazar, J.P.
000169146 700__ $$0(orcid)0000-0003-0178-4567$$aBorque-Fernando, Á.$$uUniversidad de Zaragoza
000169146 700__ $$aMoreno-Sierra, J.
000169146 700__ $$aCollen, S.
000169146 700__ $$aBeyer, K.
000169146 700__ $$aHelleman, J.
000169146 700__ $$aRoobol, M.J.
000169146 700__ $$avan Poppel, H.
000169146 7102_ $$11013$$2817$$aUniversidad de Zaragoza$$bDpto. Cirugía$$cÁrea Urología
000169146 773__ $$g(2025), 501919 [6 pp.]$$pActas urol. esp.$$tActas urológicas españolas$$x0210-4806
000169146 8564_ $$s1052018$$uhttps://zaguan.unizar.es/record/169146/files/texto_completo.pdf$$yVersión publicada
000169146 8564_ $$s2285917$$uhttps://zaguan.unizar.es/record/169146/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000169146 909CO $$ooai:zaguan.unizar.es:169146$$particulos$$pdriver
000169146 951__ $$a2026-02-20-14:53:51
000169146 980__ $$aARTICLE